Carl Zeiss Meditec (ETR:AFX) Shares Down 4.9% – Time to Sell?

Carl Zeiss Meditec AG (ETR:AFXGet Free Report) traded down 4.9% on Thursday . The company traded as low as €57.60 ($62.61) and last traded at €57.60 ($62.61). 266,723 shares traded hands during trading, an increase of 183% from the average session volume of 94,405 shares. The stock had previously closed at €60.55 ($65.82).

Carl Zeiss Meditec Stock Down 0.5 %

The firm has a fifty day simple moving average of €62.73 and a 200-day simple moving average of €72.68. The company has a market capitalization of $5.12 billion, a PE ratio of 25.13, a P/E/G ratio of 2.83 and a beta of 0.98. The company has a debt-to-equity ratio of 6.74, a quick ratio of 2.47 and a current ratio of 3.51.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Featured Articles

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.